Skip to content

Clinical trials

Sarcoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Country / region: Japan Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20081
20111
20141
20153
20161
20171
20191
20202
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting7
Active, not recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Bayer2
Eisai Co., Ltd.2
GlaxoSmithKline2
Japan Rhabdomyosarcoma Study Group2
EMD Serono Research & Development Institute, Inc.1
Gynecologic Oncology Group1
Hoffmann-La Roche1
Merck KGaA, Darmstadt, Germany1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma20
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms5
Colorectal Neoplasms4
Biliary Tract Neoplasms3
Head and Neck Neoplasms3
Neoplasms3
Neuroendocrine Tumors3
Ovarian Neoplasms3
Thyroid Neoplasms3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.